Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ELTP_Elite Pharmaceuticals!!!!!
ELTP now 5 products launched
3 of them since the begining of 2012
Next 3 by the end of the year !
Phentermine HCl , 37.5 mg tablets 2011
Phentermine HCI, 15 mg capsules 11/12 2012
Phentermine HCI, 30 mg capsules 11/12 2012
Hydromorphone Hydrochloride, 8 mg tablets 2012
Lodrane D® 2011
Methadone Hydrochloride, 10 mg tablets 2012
Phendimetrazine Tartrate Tablets USP,35 mg. 2012
Naltrexone Hydrochloride, 50 mg 11/12 2012
Timing Is Everything !
NOW is opportunity to buy !
Revenues improved y/y 130 %
Q/Q 10 - 20%
Products:
http://www.elitepharma.com/product_pipeline.asp
Elite Pharmaceuticals_ELTP!!!!!!
ELTP now 5 products launched
3 of them since the begining of 2012
Next 3 by the end of the year !
Phentermine HCl , 37.5 mg tablets 2011
Phentermine HCI, 15 mg capsules 11/12 2012
Phentermine HCI, 30 mg capsules 11/12 2012
Hydromorphone Hydrochloride, 8 mg tablets 2012
Lodrane D® 2011
Methadone Hydrochloride, 10 mg tablets 2012
Phendimetrazine Tartrate Tablets USP,35 mg. 2012
Naltrexone Hydrochloride, 50 mg 11/12 2012
Timing Is Everything
NOW is opportunity to buy !
Revenues improved y/y 130 %
Q/Q 10 - 20%
Products:
http://www.elitepharma.com/product_pipeline.asp
Elite Pharmaceuticals_ELTP
ELTP now 5 products launched
3 of them since the begining of 2012
Next 3 by the end of the year !
Phentermine HCl , 37.5 mg tablets 2011
Phentermine HCI, 15 mg capsules 11/12 2012
Phentermine HCI, 30 mg capsules 11/12 2012
Hydromorphone Hydrochloride, 8 mg tablets 2012
Lodrane D® 2011
Methadone Hydrochloride, 10 mg tablets 2012
Phendimetrazine Tartrate Tablets USP,35 mg. 2012
Naltrexone Hydrochloride, 50 mg 11/12 2012
NOW is opportunity to buy !
Revenues improved y/y 130 %
Q/Q 10 - 20%
Products:
http://www.elitepharma.com/product_pipeline.asp
Look at this ELTP
Elite Pharmaceuticals
ELTP now 5 products launched
3 of them since the begining of 2012
Next 3 by the end of the year !
Phentermine HCl , 37.5 mg tablets 2011
Phentermine HCI, 15 mg capsules 11/12 2012
Phentermine HCI, 30 mg capsules 11/12 2012
Hydromorphone Hydrochloride, 8 mg tablets 2012
Lodrane D® 2011
Methadone Hydrochloride, 10 mg tablets 2012
Phendimetrazine Tartrate Tablets USP,35 mg. 2012
Naltrexone Hydrochloride, 50 mg 11/12 2012
NOW is opportunity to buy !
Revenues improved y/y 130 %
Q/Q 10 - 20%
Products:
http://www.elitepharma.com/product_pipeline.asp
Elite Pharmaceuticals_ELTP
ELTP now 5 products launched
3 of them since the begining of 2012
Next 3 by the end of the year !
Phentermine HCl , 37.5 mg tablets 2011
Phentermine HCI, 15 mg capsules 11/12 2012
Phentermine HCI, 30 mg capsules 11/12 2012
Hydromorphone Hydrochloride, 8 mg tablets 2012
Lodrane D® 2011
Methadone Hydrochloride, 10 mg tablets 2012
Phendimetrazine Tartrate Tablets USP,35 mg. 2012
Naltrexone Hydrochloride, 50 mg 11/12 2012
NOW is opportunity to buy !
Revenues improved y/y 130 %
Q/Q 10 - 20%
Products:
http://www.elitepharma.com/product_pipeline.asp
Look at this ELTP
Elite Pharmaceuticals
ELTP now 5 products launched
3 of them since the begining of 2012
Next 3 by the end of the year !
Phentermine HCl , 37.5 mg tablets 2011
Phentermine HCI, 15 mg capsules 11/12 2012
Phentermine HCI, 30 mg capsules 11/12 2012
Hydromorphone Hydrochloride, 8 mg tablets 2012
Lodrane D® 2011
Methadone Hydrochloride, 10 mg tablets 2012
Phendimetrazine Tartrate Tablets USP,35 mg. 2012
Naltrexone Hydrochloride, 50 mg 11/12 2012
NOW is opportunity to buy !
Revenues improved y/y 130 %
Q/Q 10 - 20%
Products:
http://www.elitepharma.com/product_pipeline.asp
Look at this ELTP
Elite Pharmaceuticals
ELTP now 5 products launched
3 of them since the begining of 2012
Next 3 by the end of the year !
Phentermine HCl , 37.5 mg tablets 2011
Phentermine HCI, 15 mg capsules 11/12 2012
Phentermine HCI, 30 mg capsules 11/12 2012
Hydromorphone Hydrochloride, 8 mg tablets 2012
Lodrane D® 2011
Methadone Hydrochloride, 10 mg tablets 2012
Phendimetrazine Tartrate Tablets USP,35 mg. 2012
Naltrexone Hydrochloride, 50 mg 11/12 2012
NOW is opportunity to buy !
Revenues improved y/y 130 %
Q/Q 10 - 20%
Products:
http://www.elitepharma.com/product_pipeline.asp
Look at this_/_/_/
Elite Pharmaceuticals
ELTP now 5 products launched
3 of them since the begining of 2012
Next 3 by the end of the year !
Phentermine HCl , 37.5 mg tablets 2011
Phentermine HCI, 15 mg capsules 11/12 2012
Phentermine HCI, 30 mg capsules 11/12 2012
Hydromorphone Hydrochloride, 8 mg tablets 2012
Lodrane D® 2011
Methadone Hydrochloride, 10 mg tablets 2012
Phendimetrazine Tartrate Tablets USP,35 mg. 2012
Naltrexone Hydrochloride, 50 mg 11/12 2012
NOW is opportunity to buy !
Revenues improved y/y 130 %
Q/Q 10 - 20%
Products:
http://www.elitepharma.com/product_pipeline.asp
Elite Pharmaceuticals_ELTP
ELTP now 5 products launched
3 of them since the begining of 2012
Next 3 by the end of the year !
Phentermine HCl , 37.5 mg tablets 2011
Phentermine HCI, 15 mg capsules 11/12 2012
Phentermine HCI, 30 mg capsules 11/12 2012
Hydromorphone Hydrochloride, 8 mg tablets 2012
Lodrane D® 2011
Methadone Hydrochloride, 10 mg tablets 2012
Phendimetrazine Tartrate Tablets USP,35 mg. 2012
Naltrexone Hydrochloride, 50 mg 11/12 2012
NOW is opportunity to buy !
Revenues improved y/y 130 %
Q/Q 10 - 20%
Products:
http://www.elitepharma.com/product_pipeline.asp
Manufacturing Fees
4Q2012 _ 272,218$
1Q2013 _ 379,697$
2Q2013 _ 466,020$
3Q2013 _ Current quarter.
Phendimetrazine Tablet added a few days ago.
Phentermine HCI, 15 mg and 30 mg and Naltrexone hopefully soon.
.
Jerry Treppel, Chairman and CEO of Elite commented,
"Our plan to increase revenues from product sales, which are inherently more stable and predictable than a milestone based revenue stream continues apace.
We have manufactured larger batches of product in our new facility and begun limited packaging operations as well
Elite Pharmaceuticals_ELTP
ELTP now 5 products launched
3 of them since the begining of 2012
Next 3 by the end of the year !
Phentermine HCl , 37.5 mg tablets 2011
Phentermine HCI, 15 mg capsules 11/12 2012
Phentermine HCI, 30 mg capsules 11/12 2012
Hydromorphone Hydrochloride, 8 mg tablets 2012
Lodrane D® 2011
Methadone Hydrochloride, 10 mg tablets 2012
Phendimetrazine Tartrate Tablets USP,35 mg. 2012
Naltrexone Hydrochloride, 50 mg 11/12 2012
NOW is opportunity to buy !
Revenues improved y/y 130 %
Q/Q 10 - 20%
Products:
http://www.elitepharma.com/product_pipeline.asp
Elite Pharmaceuticals_ELTP
ELTP now 5 products launched
3 of them since the begining of 2012
Next 3 by the end of the year !
Phentermine HCl , 37.5 mg tablets 2011
Phentermine HCI, 15 mg capsules 11/12 2012
Phentermine HCI, 30 mg capsules 11/12 2012
Hydromorphone Hydrochloride, 8 mg tablets 2012
Lodrane D® 2011
Methadone Hydrochloride, 10 mg tablets 2012
Phendimetrazine Tartrate Tablets USP,35 mg. 2012
Naltrexone Hydrochloride, 50 mg 11/12 2012
NOW is opportunity to buy !
Revenues improved y/y 130 %
Q/Q 10 - 20%
Products:
http://www.elitepharma.com/product_pipeline.asp
Elite Pharmaceuticals_ELTP
ELTP now 5 products launched
3 of them since the begining of 2012
Next 3 by the end of the year !
Phentermine HCl , 37.5 mg tablets 2011
Phentermine HCI, 15 mg capsules 11/12 2012
Phentermine HCI, 30 mg capsules 11/12 2012
Hydromorphone Hydrochloride, 8 mg tablets 2012
Lodrane D® 2011
Methadone Hydrochloride, 10 mg tablets 2012
Phendimetrazine Tartrate Tablets USP,35 mg. 2012
Naltrexone Hydrochloride, 50 mg 11/12 2012
NOW is opportunity to buy !
Revenues improved y/y 130 %
Q/Q 10 - 20%
Products:
http://www.elitepharma.com/product_pipeline.asp
Elite Pharmaceuticals_ELTP
ELTP now 5 products launched
3 of them since the begining of 2012
Next 3 by the end of the year !
Phentermine HCl , 37.5 mg tablets 2011
Phentermine HCI, 15 mg capsules 11/12 2012
Phentermine HCI, 30 mg capsules 11/12 2012
Hydromorphone Hydrochloride, 8 mg tablets 2012
Lodrane D® 2011
Methadone Hydrochloride, 10 mg tablets 2012
Phendimetrazine Tartrate Tablets USP,35 mg. 2012
Naltrexone Hydrochloride, 50 mg 11/12 2012
NOW is opportunity to buy !
Revenues improved y/y 130 %
Q/Q 10 - 20%
Products:
http://www.elitepharma.com/product_pipeline.asp
Elite Pharmaceuticals ELTP [/color]
ELTP now 5 products launched
3 of them since the begining of 2012
Next 3 by the end of the year !
Phentermine HCl , 37.5 mg tablets 2011
Phentermine HCI, 15 mg capsules 11/12 2012
Phentermine HCI, 30 mg capsules 11/12 2012
Hydromorphone Hydrochloride, 8 mg tablets 2012
Lodrane D® 2011
Methadone Hydrochloride, 10 mg tablets 2012
Phendimetrazine Tartrate Tablets USP,35 mg. 2012
Naltrexone Hydrochloride, 50 mg 11/12 2012
NOW is opportunity to buy
Revenues improved y/y 130 %
Q/Q 10 - 20%
Products:
http://www.elitepharma.com/product_pipeline.asp
Elite Pharmaceuticals ELTP
ELTP now 5 products launched
3 of them since the begining of 2012
Next 3 by the end of the year !
Phentermine HCl , 37.5 mg tablets 2011
Phentermine HCI, 15 mg capsules 11/12 2012
Phentermine HCI, 30 mg capsules 11/12 2012
Hydromorphone Hydrochloride, 8 mg tablets 2012
Lodrane D® 2011
Methadone Hydrochloride, 10 mg tablets 2012
Phendimetrazine Tartrate Tablets USP,35 mg. 2012
Naltrexone Hydrochloride, 50 mg 11/12 2012
NOW is opportunity to buy !
Revenues improved y/y 130 %
Q/Q 10 - 20%
Products:
http://www.elitepharma.com/product_pipeline.asp
Elite Pharmaceuticals_ELTP
ELTP now 5 products launched
3 of them since the begining of 2012
Next 3 by the end of the year !
Phentermine HCl , 37.5 mg tablets 2011
Phentermine HCI, 15 mg capsules 11/12 2012
Phentermine HCI, 30 mg capsules 11/12 2012
Hydromorphone Hydrochloride, 8 mg tablets 2012
Lodrane D® 2011
Methadone Hydrochloride, 10 mg tablets 2012
Phendimetrazine Tartrate Tablets USP,35 mg. 2012
Naltrexone Hydrochloride, 50 mg 11/12 2012
NOW is opportunity to buy ! Revenues improved y/y 130 %
Q/Q 10 - 20%
Products:
http://www.elitepharma.com/product_pipeline.asp
Elite Pharmaceuticals ELTP
ELTP now 5 products launched
3 of them since the begining of 2012
Next 3 by the end of the year !
Phentermine HCl , 37.5 mg tablets 2011
Phentermine HCI, 15 mg capsules 11/12 2012
Phentermine HCI, 30 mg capsules 11/12 2012
Hydromorphone Hydrochloride, 8 mg tablets 2012
Lodrane D® 2011
Methadone Hydrochloride, 10 mg tablets 2012
Phendimetrazine Tartrate Tablets USP,35 mg. 2012
Naltrexone Hydrochloride, 50 mg 11/12 2012
NOW opportunity to buy !
Revenues improved y/y 130 %
Q/Q 10 - 20%
Products:
http://www.elitepharma.com/product_pipeline.asp
ELTP now 5 products launched
Three of them since the begining of 2012
Next three by the end of the year !
Phentermine HCl , 37.5 mg tablets 2011
Phentermine HCI, 15 mg capsules 11/12 2012
Phentermine HCI, 30 mg capsules 11/12 2012
Hydromorphone Hydrochloride, 8 mg tablets 2012
Lodrane D® 2011
Methadone Hydrochloride, 10 mg tablets 2012
Phendimetrazine Tartrate Tablets USP,35 mg. 2012
Naltrexone Hydrochloride, 50 mg 11/12 2012
Revenues improving y/y 130 %
Q/Q 10 - 20%
Products:
http://www.elitepharma.com/product_pipeline.asp
Phendimetrazine Tartrate Tablets USP, 35 mg.
Product Pipeline
http://www.elitepharma.com/product_pipeline.asp
Very good news :)
Elite Pharmaceuticals Announces First Shipment of Generic Phendimetrazine Tablet Product
Elite Pharmaceuticals, Inc. (“Elite”) (OTCBB: ELTP) announced today the initial shipment of Phendimetrazine tartrate 35 mg tablets, the generic equivalent of Bontril PDM® 35 mg tablets under the previously announced manufacturing and supply agreement with Mikah Pharma (“Mikah”). Actavis, Inc. (“Actavis”), recently acquired by Watson Pharmaceuticals Inc. (“Watson”), will distribute the product as part of a distribution agreement between Mikah and Actavis.
When we can expect Naltrexone ?
"Please note that this transfer to the Northvale Facility has been significantly delayed, as a result of the Company being notified by the U.S. Food and Drug Administration (the “FDA”) of its reclassification of our CBE-30 supplement to a prior approval supplement. The transfer of the manufacturing process of naltrexone is a prerequisite to the commercial launch of this generic product. We believe that the commercial launch of
this generic product will be a material event and any delays in such launch will have a significant and adverse effect on the Company’s operation and results."
And how much is Phentermine HCl 37.5mg affected by API restriction ? is next question...
Latest links referring ELTP
The video to learn about the probability of Elite Pharmaceuticals, Inc. (ELTP)
http://www.hotstocked.com/companies/e/elite-pharmaceuticals-inc-ELTP-level2-93294.html
.
ELTP in top 10 tips
http://theshareprice.com/netflix-target-for-takeover/
/TheSharePrice.com is a dynamic Investment community that offers the best investment tips on the internet and provides investors with a simple way to share their tips and advice with others without the hassle of signing up/
.
http://www.webrtcworld.com/news/2012/11/04/6698376.htm
Probably :) We will see.
Thursday,Thursday - was also WRONG
...
OVERSOLD : BUY
Buy anything under 0,1149 !!!
Nobody knows
We need some HUGE PATENT to get PPS back above 0,15
OVERSOLD
"I also called the approval"
On Elite products page, Naltrexone is still "Pending FDA Approval of Product Transfer"
How do we know, that product transfer was approved ?
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=NALTREXONE%20HYDROCHLORIDE
Original Approval or Tentative Approval Date May 26, 1999
ELTP license or contract manufacture four products currently being sold commercially :
· Phentermine 37.5mg tablets (“Phentermine 37.5mg”) _2011
· Lodrane D® Immediate Release capsules (“Lodrane D”) _2011
· Methadone 10mg tablets (“Methadone 10mg”) _2012
· Hydromorphone Hydrochloride 8mg tablets(Hydromorphone 8mg)_2012
Elite’s revenues derived during the three months ended June 30, 2012
from phentermine 37.5mg tablets were approximately $162k
from Lodrane D® were approximately $142k
from Methadone 10mg tablets were approximately $128k
from Hydromorphone 8mg tablets were approximately $78k
After BUY recommendation on 10.02.2012, price went down.
Now when the price is -7% and stock has SELL recommendation, price will go up. It is logical.
.
So it is time to buy. Monday and Tuesday will confirm it, IMO.
Higher highs and higher lows
3 years chart shows direction
http://ih.advfn.com/p.php?pid=webchart&btn=s_ok&ctl00%24sb3%24tbq1=Get+Quote&as_values_IH=&ctl00%24sb3%24stb1=Search+iHub&symbol=OTCBB%3AELTP&s_ok=Get+Chart&period=7&drawmode=0&size=19&volume=1
In April 2011 they had 1 product, in April 2013 they will have producing 7-9 products?
With more employees on doubled manufacturing space
It will influence the stock price positively
A heads-up on pharmaceuticals in late-stage development
Pain New drugs September 2012
http://formularyjournal.modernmedicine.com/formulary/data/articlestandard/formulary/382012/789672/article.pdf
It looks like "message" for a potential partner(s) with whom Elite is negotiating, saying
We have also another option, how to do our business
?
Yes, a year ago they had one product after they lost the only production stream.
Now 4 products launched, 3 expected this autumn and also second 15,000 square feet of manufacturing space will start operate soon.
Company with growing potential...
ELTP set to next run to 0,20 -0,25
Products:
http://www.elitepharma.com/product_pipeline.asp
What is expected soon :
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=79168625
Chart:
http://ih.advfn.com/p.php?pid=webchart&btn=s_ok&ctl00%24sb3%24tbq1=Get+Quote&as_values_IH=&ctl00%24sb3%24stb1=Search+iHub&symbol=OTCBB%3AELTP&s_ok=Get+Chart&period=7&drawmode=0&size=19&volume=1
Opioid Abuse, Abuse Deterrent Products..
http://www.pharmacytimes.com/publications/issue/2012/August2012/Novel-Tactics-Deterring-Opioid-Abuse
We have made progress on many fronts
Our currently marketed products continue to grow generating more revenue for Elite
Our development projects with clients continue to move forward
The development of our abuse-resistance products continue to move forward
We are just now completing an FDA general cGMP review and several pre-approval inspection reviews of our facility
.
In 2 -3 months , Elite will be with 1 or 2 new products approved and with the new manufacturing space working
And comparing 274K revenues of 2012-Q2 with revenues of 2013-Q2 will be completely different
JULY 03, 2012 Conference call
Jerry Treppel - Elite Pharmaceuticals, Inc. - Chairman and CEO
2012 was a year in which we started from zero and created $2.4 million in new revenues.
Chris Dick - Elite Pharmaceuticals, Inc. - COO and President
We don't give out projections, just as a matter of policy, but I can tell you that we are looking at a revenue run rate of around $4 million. It very much depends on the product mix, but generally under most reasonable scenarios, right around the $4 million run rate is where we turn cash flow positive.
We are expecting to reach those levels where we were once at by the end of this fiscal year. So roughly 9 months or so from now is what we are expecting as far as reaching the levels that we were at prior to the Lodrane being removed.
Jerry Treppel - Elite Pharmaceuticals, Inc. - Chairman and CEO
Just like previously, that requires us to get to an annual run rate of a little over $4 million, and Carter can correct me if I'm wrong about that, but I think that's correct. We are getting there; we're definitely getting there. With a little help from the FDA, we will get there in fiscal 2013
Questions :
Are you still expecting revenues of around 4 million at the end of fiscal 2013 ?
.
What does little help from FDA mean ?( approval of Naltrexone by the end of September or approval of a new facility by ?…or approval of all pending products in 2012 ?........)
Yes it is, of course
http://www.globenewswire.com/newsroom/news.html?d=233313
See also this page - Commercial Products
Lodrane 24h Products NDA Scale-up partner ECR...